Victorian Heart Hospital: world-first clinical trial for cholesterol treatment
First-in-human trial of cholesterol-lowering CRISPR epigenetic silencing therapy to begin at Victorian Heart Hospital.
Polycystic ovary syndrome renamed to reflect condition’s complexity
For decades, the name ‘polycystic ovary syndrome’ has left many patients confused and some misdiagnosed. A landmark rename could change how the condition is understood, treated, and talked about.
World-first study links poor childhood sleep to PMOS diagnosis
A world-first study has found that girls with polycystic ovary syndrome (PCOS) had significantly poorer sleep behaviour across childhood and adolescence, compared to girls without PCOS.